OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
P/E ratio for OrthoPediatrics Corp. (KIDS)
P/E ratio as of 2023: -35.15
According to OrthoPediatrics Corp.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -35.15. At the end of 2022 the company had a P/E ratio of 653.89.
P/E ratio history for OrthoPediatrics Corp. from 2014 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -35.15 |
| 2022 | 653.89 |
| 2021 | -70.93 |
| 2020 | -22.61 |
| 2019 | -39.96 |
| 2018 | -36.45 |
| 2017 | -10.35 |
| 2016 | -21.97 |
| 2015 | -18.30 |
| 2014 | -14.97 |